Ing Groep Nv Eloxx Pharmaceuticals, Inc. Transaction History

Ing Groep Nv

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 08, 2019	SELL	$4.37 - $9.91 $131,100 - $297,300	-30,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.77 - $12.49 $263,100 - $374,700	30,000 New	30,000 $299,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.